Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Precision Medicine With Ketamine for Older Adults With Treatment-resistant Depression: Pilot Study

To see complete record on, please visit this link

Id: NCT04504175

Organisation Name: Washington University School of Medicine

Overal Status: Completed

Start Date: October 22, 2020

Last Update: April 27, 2022

Lead Sponsor: Washington University School of Medicine

Brief Summary: This pilot study will assess the safety and feasibility of intravenous (IV) ketamine in older adults with Treatment-Resistant Depression (TRD). In addition, this study will develop and utilize innovative methodological approaches to demonstrate the feasibility of precision medicine and mobile health approaches in depression treatment.

  • Treatment Resistant Depression
  • Refractory Depression
  • Therapy-Resistant Depression
  • Late Life Depression
  • Geriatric Depression

Total execution time in seconds: 0.31594491004944